P

POLB-001

Product

by Poolbeg Pharma plc

Heard in 2 episodes across 1 show since May 2026

POLB-001 is an investigational oral immunomodulator and p38 MAP kinase inhibitor being developed to prevent or reduce cytokine release syndrome (CRS), a potentially life-threatening inflammatory reaction associated with cancer immunotherapies. The candidate is intended to make these treatments safer and potentially enable their administration in a broader range of healthcare settings.

Episodes

2
across 1 show

First heard

May 2026

Expert statements

3
3 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20250
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20261
Jun 20260
Jul 20260
Aug 20261
Sep 20260
Oct 20260

What experts have said about POLB-001

3 statements · 3 positive

  1. Jeremy ScheppersPositiveAug 2, 2026· The Sunday Roast

    Poolbeg aims to enroll approximately 30 patients in its POLB-001 trial.

    “our ultimate goal is to kind of build this up to roughly or approximately 30 patients”

    Listen at 35:23

    Open the episode · S11 Ep93: The Sunday Roast, Mid-Summer Special featuring African Pioneer, Poolbeg Pharma, Technology Minerals, Talon Resources and Ajax Resources plc #AFP #POLB #TM1 #TAR #AJAX
  2. Jeremy ScheppersPositiveAug 2, 2026· The Sunday Roast

    Poolbeg expects trial data to enable partnering of POLB-001.

    “we believe that we'll be able to partner the program because we've started really productive discussions”

    Listen at 35:30

    Open the episode · S11 Ep93: The Sunday Roast, Mid-Summer Special featuring African Pioneer, Poolbeg Pharma, Technology Minerals, Talon Resources and Ajax Resources plc #AFP #POLB #TM1 #TAR #AJAX
  3. Jeremy ScheppersPositiveAug 2, 2026· The Sunday Roast

    Poolbeg expects POLB-001 to reduce or eliminate cytokine release syndrome.

    “we're going to reduce or eliminate CRS”

    Listen at 48:47

    Open the episode · S11 Ep93: The Sunday Roast, Mid-Summer Special featuring African Pioneer, Poolbeg Pharma, Technology Minerals, Talon Resources and Ajax Resources plc #AFP #POLB #TM1 #TAR #AJAX

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

2 episodes featuring POLB-001, newest first

POLB-001 · PodLume